Research Progress and Application Prospects of Bioaffinity Chromatography in Screening Cardiotoxic Components of Chinese Herbal Medicines Authors: Huimin Lin, Jiaxuan Zhu, Leyao Xian, Hongjin Chen, Dawei Zou, Jingdan Zhang, Xiuye Huang, Yufeng Huang, Fan He Published: 2026 ABSTRACT With the continuous expansion of the clinical application of Chinese herbal medicines (CHMs), the cardiotoxicity risk of certain herbs or naturally derived substances traditionally considered “safe” has gradually emerged. This paper systematically explores the potential of bioaffinity chromatography as an efficient screening tool for identifying cardiotoxic components from complex CHM matrices through a literature review conducted across multiple databases using keywords such as “cardiotoxicity,” “bioaffinity chromatography,” “aconitine,” and “bioactivity.” The clinical manifestations and molecular mechanisms of CHM-induced cardiotoxicity were first reviewed, focusing on ion channel dysfunction, mitochondrial damage, apoptosis, and metabolic disorders. Subsequently, a detailed discussion of the five main bioaffinity chromatography techniques, including immunoaffinity chromatography, lectin affinity chromatography, cell membrane chromatography, receptor affinity chromatography, and DNA affinity chromatography, was provided, highlighting their principles and applications in screening the bioactivity from herbs. For the first time, it is proposed to apply bioaffinity chromatography technology to screen components in CHMs that have cardiotoxic effects through specific biological interactions. This enables targeted and high-throughput identification of cardiotoxic compounds and highlights its potential in early cardiotoxicity prediction and mechanistic studies. This review aims to provide a methodological framework for shifting the safety evaluation of CHMs from reactive analysis to proactive risk warning, thereby supporting the rational and safe clinical use of CHMs. Introduction The global application of Chinese herbal medicines (CHMs) raises significant safety concerns, with drug-induced cardiotoxicity representing a particularly severe and unpredictable risk. − Figure shows that this toxicity is insidious because it can arise not only from known toxic herbs like Aconitum but also from traditionally “safe” herbs, revealing critical gaps in our predictive capabilities. − The core challenge in preemptively identifying cardiotoxic components lies in the inherent complexity of CHMs, which are multicomponent systems that may induce toxicity through multiple, overlapping molecular pathways, such as ion channel disruption and mitochondrial dysfunction. , Cardiotoxicity of Chinese herbal medicines. Traditional phytochemical screening, which focuses on isolating and testing individual compounds, is not suited to this complexity. It is slow, often misses trace toxicants, and fails to prioritize compounds on the basis of their biological relevance. Consequently, the safety assessment remains largely reactive. There is an urgent need for screening paradigms that can directly probe the bioactivity space of CHMs and efficiently fish out components that interact with pivotal cardiac targets. Bioaffinity chromatography holds promise as a feasible approach to addressing this challenge. By immobilizing biological targets, such as proteins, membranes, or cells, as chromatographic ligands, this technique can directly and selectively capture interacting compounds from complex extracts. Its advantage lies in bridging, to some extent, the knowledge gap between chemical complexity and biological effects. At present, bioaffinity chromatography has been widely applied in the screening of active components in traditional Chinese medicine, and there have been reports of its use in identifying components in herbal medicines that counteract cardiotoxicity. In practice, compared with treatment, we believe that prevention is more important. On the basis of the characteristics of this technology, we are confident that it also holds significant potential for exploring cardiotoxic components in CHMs. In this review, we move beyond a descriptive catalog of techniques. We first establish the “problem space” by summarizing the key cardiac targets and mechanisms implicated in CHM toxicity. Introducing bioaffinity chromatography technology into the study of cardiotoxicity of CHMs can efficiently screen toxic components and also facilitate an in-depth investigation of the component-target interaction mechanisms. This provides data support for constructing toxicity prediction models and is expected to shift CHM toxicity screening from “post-analysis” to “proactive prediction”, thereby enhancing the clinical safety of CHM use. This paper reviews the current status of research on cardiotoxicity induced by CHMs, explains the principles and applications of bioaffinity chromatography, and explores its innovative value and challenges in screening cardiotoxic components. By promoting mechanistic research through material-based studies, it offers new support and reference for building clinical safety evaluation frameworks. Clinical Manifestations and Mechanisms of CHM-Induced Cardiotoxicity Clinical Manifestations The course and mechanism of herb-induced cardiotoxicity involve complex regulation by multiple factors, including drug properties, individual differences, and medication regimens. The resulting cardiotoxic effects can manifest as a wide range of clinical symptoms, from mild gastrointestinal discomfort and hypotension to severe ventricular arrhythmias and cardiac arrest. − Table summarizes representative herbs with cardiotoxic potential and their associated clinical effects. For instance, aconitine can cause life-threatening ventricular tachycardia and ventricular fibrillation; Tripterygii Radix et Rhizoma may lead to elevated cardiac biomarkers such as troponin and CK-MB; while glycyrrhizic acid can induce hypokalemia-mediated arrhythmias. , These cases underscore the importance of vigilant cardiac monitoring for patients using herbal medicines, particularly those with a history of cardiovascular diseases. 1Cardiotoxicity from Different Chinese Herbal Medicines TCM (pingyin) TCM (Latin) main toxic components toxic target organs cardiotoxicity target cardiotoxicity manifestations references Chuanwu Aconitum carmichaelii Debx.aconitine, mesaconitine, hypaconitineheart, nervous system, and liverhERG, Nav1.5, CaV1.2the subjects experienced tachycardia, fibrillation, and torsades de pointes Leigongteng Tripterygium wilfordii Hook. f.celastrol, triptolide, and triptonideliver, kidney, heart, ears and genital organshERG, Bax, P53electrocardiogram (ECG) abnormalities included sinus tachycardia, diffuse low voltage, a QS pattern in leads V1 and V2, and a wide QRS complex Shandougen Sophora tonkinensis Gagnep.matrine and sophocarpine nervous system, liver, and hearthERG, Nav1.5, Na+ K+-ATPase, NCXthe treatment induced cardiomyocyte injury, impaired cardiac function, and bradycardia Wuzhuyu Tetradium ruticarpum (A.Juss.) T.G.Hartleyevodiamine, dehydroevodia-mine, and hortiamineliver, hearthERG, LDH, SODDHE administration resulted in bradycardia, hypotension, and vasorelaxation Pishuangarsenic trioxideAs2O3 liver, stomach, heart, spanhERG, ATPase, ROS, PGC-1αcardiotoxicity manifested as QT prolongation, torsades de pointes (TdP), and sudden cardiac death Gancao Glycyrrhiza uralensis Fisch. ex-DC.glycyrrhetinic acidheart11βHSDHthe animals exhibited marked ECG disturbances, such as ST-segment elevation and pathological Q waves, along with a significant decrease in heart rate Chansu Bufo bufo gargarizans Cantorbufosteroidsheart, liverNa+/K+-ATPase, MDA, ROSpolymorphic ventricular arrhythmia was observed, which was characterized by a prolonged QT interval, junctional escape beats, and R-on-T ventricular premature complexes Cangerzi Xanthium strumarium L.carboxyatractyloside and atractylosideliver, heart, nervous system, and skinadenine nucleotide translocase (ANT)manifestations of cardiotoxicity included ECG abnormalities (ST-T changes, sinus or ventricular tachycardia, and asystole), elevated cardiac enzymes (CK, LDH, and CK-MB), and potential progression to acute left-sided heart failure and cardiogenic shock Mahuang Ephedra sinica Stapf.ephedrineheart, nervous system and liverKCNQ1/KCNE1, α1A-adrenoceptor mediated, α-adrenoceptorshistopathological examination revealed cardiac hemorrhage, degeneration of the interventricular septum and left ventricle, cytoplasmic clearing and vacuolization, and myofiber necrosis Heshouwu Reynoutria multiflora (Thunb.) Moldenkerheinliver, kidney, heartROS, SOD, MMP, cTnT, CK, LDHcardiotoxicity was characterized by myocardial degeneration and necrosis with inflammatory infiltration, ECG abnormalities (prolonged PR and RR intervals, tachycardia), elevated serum biomarkers (cTnT, CK, LDH), impaired cardiac function (reduced LVEF and LVFS), and ultimately heart failure Gansui Euphorbia kansui T. N. Liou ex T. P. Wangingenane-type diterpenoidsliver, stomach, heartlactate dehydrogenase A (LDHA), α-hydroxybutyrate dehydrogenase (α-HBDH)cardiac developmental abnormalities were observed, including pericardial edema and abnormal looping, which were accompanied by bradycardia Maqianzi Strychnos nux-vomica L.strychnineliver, kidney, hearthERGin isolated hearts, a prolonged QT interval and a reduced heart rate were observed Cardiotoxicity from Different Chinese Herbal Medicines Molecular Mechanisms Ion Channel Dysfunction Cardiac ion channels are the foundation for maintaining the normal electrophysiological activity of the heart. Their functional abnormalities can directly lead to disorders of myocardial automaticity, excitability, and conductivity, which trigger various arrhythmias. This is one of the most common and central mechanisms underlying cardiotoxicity induced by CHMs. The core targets are myocardial membrane ion channel proteins, mainly including Nav1.5 sodium channels, hERG potassium channels, and Cav1.2 calcium channels. , Aconitine delays sodium channel inactivation, causing persistent Na+ influx and triggering arrhythmias. Bufalin inhibits Nav1.5 while increasing late sodium current, promoting delayed afterdepolarization. Compounds such as triptolide or sanguinarine can inhibit the hERG potassium channel and prolong the QT interval; , triptolide can also inhibit Nav1.5 and Nav1.7 channels and modulate their activation and inactivation processes, raising the risk of arrhythmias. Aconitine activates ryanodine receptors (RyR2), causing intracellular Ca2+ overload and contractile dysfunction. Mitochondrial Damage and Oxidative Stress Mitochondria are not only the core of energy metabolism in cardiomyocytes but also the main source of reactive oxygen species (ROS); oxidative stress not only induces mitochondrial damage but also amplifies its extent. The interaction between the two forms a vicious cycle, jointly mediating the cardiotoxicity of CHMs, leading to cardiomyocyte injury, apoptosis, and even necrosis, which is the core synergistic mechanism of CHM-induced myocardial injury. Certain herbs induce cardiotoxicity by impairing mitochondrial function. For instance, aconitine triggers mitochondrial apoptosis by upregulating pro-apoptotic proteins (BAX, Cyto C, and caspase-3) and downregulating Bcl-2. It also inhibits cytochrome oxidase, leading to ATP depletion and ROS accumulation. Tripterygii Radix et Rhizoma suppresses FOXO3-mediated antioxidant defenses (Mn-SOD and CAT), resulting in oxidative stress and mitochondrial membrane potential disruption. Evodiamine can increase intracellular ROS levels in cardiomyocytes, inducing lipid peroxidation, altering cardiomyocyte membrane stability, and ultimately causing myocardial injury. Apoptosis Figure shows that apoptosis is a key end point in many cardiotoxic pathways. In addition to the mitochondrial apoptosis pathway, CHMs such as arsenic trioxide (As2O3) induce continuous activation of three endoplasmic reticulum response (ER) stimulation sensors, ATF6, PERK, and IRE1, triggering a continuous unfolded protein response and activating the caspase cascade. P53-mediated apoptosis is also involved, precisely initiating the apoptosis program through transcription-dependent mechanisms. Triptolidin upregulates p53 and its downstream pro-apoptotic targets and promotes cardiomyocyte death. Mechanisms of cardiotoxicity induced by Chinese herbal medicines. Other Mechanisms Tripterygii Radix et Rhizoma inhibits the IKKβ–NF-κB pathway, downregulates the glucose transporter GLUT1/GLUT4, and impairs cardiac energy supply. Periplocin interferes with the tricarboxylic acid cycle and arachidonic acid metabolism, further impairing cardiac function. Bioaffinity Chromatography: Principle and Application in CHM Screening Immunoaffinity Chromatography Principle Immunoaffinity chromatography (IAC) is a highly selective separation technique based on the principle of antigen–antibody specific binding shown in Figure . It uses a highly specific “key” recognition mechanism between antibody and antigen to immobilize the antibody to the surface of the chromatographic vector through covalent bonding, forming an immunoaffinity stationary phase for accurate identification. This technology can directly capture, enrich, and purify target molecules from complex biological samples with high selectivity, significantly reducing matrix interference and providing a reliable pretreatment basis for subsequent high-precision instrumental analysis. At present, IAC is often combined with mass spectrometry and is widely used in the fields of disease diagnosis, protein purification, biological sample analysis, and screening of CHM ingredients. For example, the simultaneous purification of naringin and neohesperidin from citrus extracts results in high recovery (>94%) and reusability. IAC has also been used to remove specific components (such as C-glycosylflavonoids) from herbal extracts to study their immunomodulatory effects, demonstrating their utility in mechanistic studies. Schematic diagram of the online separation mechanism of immunoaffinity chromatography. Potential for Screening Cardiotoxic Components IAC combined with immobilized antibodies and mass spectrometry can specifically screen active components from complex CHMs and assess their pharmacological or toxic effects through component knockout. Studies using hapten immunoaffinity fishing techniques have successfully identified AIF1 as the direct protein target of Panax notoginseng saponins in the brain tissue of mice with cerebral hemorrhage. This method can also be used to discover the direct target actions of CHM components in the myocardium, aiding in the elucidation of cardiotoxic mechanisms. After specifically knocking out components such as baicalin from the Gegen-Qinlian decoction using an immunoaffinity column, the activity-inducing SOD expression showed no significant change, suggesting that these components are not the key active substances. Accordingly, specifically removing suspected toxic components and comparing toxicity differences before and after can help to clarify the key toxic substances. Despite the potential risk of inadvertently removing pharmacologically active components, IAC still provides an effective means for targeted screening, target validation, and safety evaluation of cardiotoxicity in CHMs. Lectin Affinity Chromatography Principle Lectin affinity chromatography (LAC) uses lectins' ability to specifically recognize specific glycan structures to separate glycosylation products (Figure ). As a nonimmunogenic sugar-binding protein, lectins can precisely bind terminal monosaccharides or oligosaccharide motifs in glycoproteins or glycolipids through multivalent interactions to achieve selective enrichment of sugar complexes. This technology can efficiently capture target glycosylated molecules from complex samples and maintain their biological activity without prior knowledge of protein information, which is valuable in glycoproteomics and biopharmaceutical quality control. In cancer research, Con A and WGA lectin columns have been used to identify metastasis-associated glycoproteins such as galactolectin-3 in nasopharyngeal cancer. In monoclonal antibody production, LAC helps monitor the spectra of high-mannose-type glycans as a key quality attribute. Schematic diagram of the online separation mechanism of lectin affinity chromatography. Potential for Screening Cardiotoxic Components LAC utilizes immobilized lectins to specifically bind glycans and can be used to analyze the effects of CHM components on the glycosylation of cardiomyocyte glycoproteins. Abnormal glycosylation is closely related to heart diseases, such as the occurrence of modifications like glycoprotein sialylation and fucosylation during pathological processes, including heart failure and cardiomyopathy. If certain components of CHMs interfere with the glycosylation of key glycoproteins (such as ion channels and signal receptors), they may induce cardiotoxicity. This technique can enrich and identify glycoproteins with abnormal glycosylation modifications, screen for potential toxic components, and discover related biomarkers such as ceruloplasmin and clusterin, providing a basis for the early assessment of cardiotoxicity. In addition, the coronary artery endothelial lectin is involved in shear-stress sensing and the regulation of cardiac function. This technique can also be used to screen CHM components that interfere with endothelial-cardiomyocyte paracrine signaling, offering a new perspective for elucidating glycosylation-related toxicity mechanisms. Cell Membrane Chromatography Principle Cell membrane chromatography (CMC) is a biomimetic affinity chromatography technique that fixes active cell membranes on the surface of silica to form a stationary phase, using the chromatography system to simulate the specific interaction between drugs and receptors, combining the dual functions of chromatographic separation and receptor affinity. (Figure ). This technology achieves efficient drug screening and mechanism elucidation by maintaining the natural conformation of membrane proteins and simulating the interaction environment in vivo. CMC has been successfully applied to screen bioactive ingredients from CHMs. Examples include the use of MCF7-CMC to screen antibreast cancer compounds from the A. metadermalis drug pairs; identification of neuroactive Bupleurum saponins from Bupleurum using SH SY5Y-CMC; and baicalein, which uses bone marrow mononuclear CMC to find antiosteoporotic effects from scutellaria. Schematic diagram of the online separation mechanism of cell membrane chromatography. Potential for Screening Cardiotoxic Components CMC mimics cardiotoxic mechanisms (ion channel disorder, mitochondrial damage, oxidative stress, and apoptosis) by targeting cell membrane proteins (ion channels and Fas) and mitochondrial BCL family proteins. Its advantage lies in reconstructing the myocardial microenvironment and preserving all natural targets on the membrane surface, enabling the simultaneous capture of components that bind to multiple targets, which aligns with the multimechanistic synergistic characteristics of CHM toxicity. A study analyzing the rat myocardial CMC time of flight/mass spectrometry system after administration of Aconitum found that metabolic processes such as deacetylation, debenzoylation, and demethylation could reduce the affinity of components for the myocardial membrane, suggesting that such conversions may be related to processing and in vivo detoxification. To address the issues of short column lifespan and poor reproducibility in traditional columns, in situ synthesized membrane protein affinity chromatography does not require cell culture and can produce a stable, uniformly oriented stationary phase within 2 h, which has been used to screen PDGFRβ inhibitors from sage. APTES modification can covalently fix cell membranes on the silica surface, maintaining column efficiency for more than 12 days and making it suitable for two-dimensional chromatography. Mitochondrial membrane chromatography can quickly “fish out” components from CHMs that act on mitochondria (such as regulating energy metabolism or apoptosis pathways). Given the complex composition of membrane proteins, some proteins are unrelated to cardiotoxicity, which can lead to false positives in screening; studies have achieved targeted screening of single targets by overexpressing specific target membrane proteins. Receptor Affinity Chromatography Principle Receptor affinity chromatography (RAC) is a bionic chromatography technique that utilizes the specific interaction between drugs and membrane receptors, transforming the interaction process of ligands with membrane receptors in vivo into an in vitro chromatographic analysis process (Figure ). The mild, efficient, and receptor-structure-preserving immobilization method of RAC ensures relatively high column efficiency. The gentle receptor immobilization method gives it high activity. Because receptor chromatography integrates the high specificity of receptor-recognizing drugs with the high separation capability of chromatography technology, it possesses high sensitivity, high specificity, high stability, and high targeted prediction ability, making it one of the important methods for online analysis of drug-receptor interactions and efficient screening of active components in complex systems. Studies have found that through affinity chromatography targeting β2-AR and stepwise frontal analysis, the main active components in Mahuang-Fuzi-Xixin Decoction include ephedrine and others. Schematic diagram of receptor affinity chromatography online separation mechanism. Potential for Screening Cardiotoxic Components The core target of RAC is membrane receptors, and the targets involved in ion channel dysfunction and apoptosis mechanisms all involve membrane receptors; therefore, RAC has inherent applicability in the study of cardiac toxicity mechanisms. To overcome the limitations of conventional immobilization strategies, such as low specificity and the need for highly purified proteins, researchers have developed several novel immobilization technologies: using Halo tags for one-step immobilization of α1A-AR, achieving column stability for up to 30 days; employing cell-free protein synthesis combined with streptavidin tag II-mediated one-step in situ oriented immobilization (oSOMAC), which allows the preparation of uniformly oriented membrane receptor stationary phases within 1–2 h; and coimmobilizing β 2 -AR with VDAC-1 to facilitate screening of dual-target active compounds. Based on these methods, RAC can analyze the binding affinity and action mode of components with cardiac ion channel receptors, predict their agonistic or inhibitory effects, and identify potential cardiotoxic compounds, providing support for mechanistic studies and safety evaluations of cardiotoxicity in CHMs. Currently, membrane receptors are mainly obtained through prokaryotic expression or overexpression in mammalian cells; however, for some receptors, structure–function relationship deviations occur due to conformational inactivation after extraction and fixation. DNA Affinity Chromatography Principle DNA affinity chromatography (DAC) utilizes DNA as a “specific bait” to capture molecules that can interact with it from complex mixtures (Figure ). It is currently used for the purification of DNA-binding proteins, the identification of protein–nucleic acid interactions, and the screening of drug molecules. DNA aptamer affinity chromatography, as a special form of DAC, employs single-stranded DNA aptamers with specific recognition capabilities as affinity ligands, replacing natural double-stranded DNA. Existing studies have used this method to discover that components in CHMs such as berberine in Coptis and phellodendron, as well as palmatine, can bind to calf thymus DNA and have measured their binding constants. Schematic diagram of the online separation mechanism of DNA affinity chromatography. Potential for Screening Cardiotoxic Components Using the regulatory sequences of genes related to myocardial apoptosis and oxidative stress as the stationary phase, DAC can be constructed to specifically enrich interacting components of traditional Chinese medicine, thereby screening for potential toxic substances that may induce genetic damage and abnormal apoptosis in cardiomyocytes by embedding into DNA, binding to promoters, or interfering with transcriptional regulation. Current studies have successfully applied aptamer-based affinity screening techniques to identify aristolochic acid I, providing a sensitive tool for detecting DNA-toxic components in the environment and food. Affinity screening platforms targeting CpG DNA have isolated compounds such as rhein and emodin from rhubarb, both of which can block the binding of CpG DNA to its receptor and inhibit inflammatory responses. This approach can also be applied to evaluate the effect of CHM components on DNA-mediated inflammatory signaling pathways in cardiomyocytes. However, free DNA lacks the nuclear microenvironment and auxiliary proteins, and the screening conditions deviate from the in vivo state, making it difficult to objectively assess the overall cardiotoxicity risk of traditional Chinese medicines when used alone. Prospects and Challenges in Cardiotoxicity Screening Upgrading the Paradigm from “Component Screening” to “Mechanism Screening” CHM component screening methods, based on phytochemical isolation, are limited in efficiency and not strongly linked to toxicity mechanisms. In contrast, the new paradigm, represented by bioaffinity chromatography screens based on the mechanisms of cardiotoxicity of traditional Chinese medicine and key targets, directly targets key cardiac proteins (such as hERG channels and myocardial mitochondrial proteins). By constructing affinity stationary phases that target pathways such as ion channels, mitochondria, apoptosis, and oxidative stress, it directly captures components involved in specific toxicity mechanisms in situ from complex systems, achieving a “mechanism-first, target-specific capture” approach. This ensures that the screening process is closely tied to toxicity mechanisms from the outset, significantly improving both its accuracy and biological relevance. Moreover, bioaffinity chromatography, based on affinity, can quantitatively evaluate the specificity and strength of binding between components and toxicological targets such as ion channels, enzymes, and receptors. High affinity generally indicates a stronger capacity to occupy the target and higher toxic potential, while characteristics such as binding strength, competitiveness, and concentration dependence provide scientific criteria for distinguishing true positives from false positives. Affinity is not only the basis for chromatographic separation but also serves as a quantitative bridge connecting components, targets, mechanisms, and toxic effects, endowing mechanism screening with scientific rigor, reliability, and predictability, and serving as a key support for achieving paradigm upgrades. Combining affinity chromatography with high-resolution detection methods can significantly enhance the throughput and accuracy of screening. Energy-resolved mass spectrometry further allows real-time analysis of ligand–protein binding strength under near-physiological conditions. For instance, a “four-in-one” liquid chromatography–energy-resolved affinity mass spectrometry platform has been developed to selectively “fish” target proteins and evaluate binding affinity, reducing false-positive rates. Strategic Reversal from “Ignoring Complexity” to “Leveraging Complexity” Traditional screening methods, such as activity-guided isolation, chemical purification-activity testing, and single-target in vitro screening, tend to explain overall toxicity using a “single component-single target” approach, but this simplified logic is difficult to apply to complex organisms. The multicomponent and multitarget nature of CHM has traditionally been a “nightmare”, considered an insurmountable interference. Using cardiomyocytes, or key receptor proteins as the stationary phase, a multitarget cell membrane/RAC system is constructed to directly apply crude extracts of traditional Chinese medicine without the need for separation and purification. This method preserves the coexistence of multiple components as well as their synergistic or antagonistic effects, avoiding the loss of activity and omission of trace components, rapidly eliminating inactive ingredients, and selectively capturing all active components that bind to cardiac targets (including trace toxic compounds), thereby directly mapping the interaction profile between traditional Chinese medicine and the heart. However, the multitarget nature of cell membranes easily introduces interference from nontoxic targets, leading to false positives. More critically, the extracted membrane proteins are detached from the cellular environment and cannot simulate authentic open or closed states. Therefore, even if a component acts on a toxic target, then CMC may not effectively screen it. Moreover, although affinity chromatography provides efficient in vitro screening, when translating research results to in vivo toxicity, factors such as pharmacokinetics, metabolism, and interorgan interactions need to be carefully considered. Compounds with strong in vitro binding may be detoxified in vivo, while prodrugs may become toxic only after metabolic activation. Therefore, positive hits from affinity screening should be validated in cellular and animal models and integrated with metabolomics and toxicokinetic studies. Capability Leap from “Unknown Risk” to “Predictable Risk” Cardiotoxicity often occurs acutely and progresses rapidly, requiring reliable early warning methods more urgently than many chronic organ toxicities. However, current evaluations of cardiotoxicity in traditional Chinese medicine still mainly rely on retrospective analysis, lacking the ability to identify toxic components and synergistic toxicity effects in complex systems in advance. The value of bioaffinity chromatography lies in its ability to use fixed cardiotoxicity targets to “fish out” components from traditional Chinese medicine extracts that may bind to them. Although the screened components are only “potential risk signals”, forming a risk candidate list for subsequent validation shifts cardiotoxicity management from retrospective tracing to early assessment. In recent years, machine learning has developed rapidly, offering advantages of efficiency, accuracy, scalability, and strong interpretability in toxicity prediction. Combining this with bioaffinity chromatography technology can open new avenues for evaluating cardiotoxicity in traditional Chinese medicine: the former can directly identify potential cardiac target-binding components from complex systems, while the latter can deeply analyze these data to reveal hidden toxicity patterns and synergistic mechanisms. This integration not only greatly enhances the accuracy and interpretability of assessments but also drives a fundamental shift in the entire safety evaluation paradigm, moving from passive response to proactive prediction. With the continuous advancement of data and algorithms, this method holds broad prospects in achieving a leap in capability from “unknown risks” to “predictable risks”. Conclusion Cardiotoxicity remains a significant safety concern in the clinical use of CHMs. Bioaffinity chromatography offers a powerful, target-oriented approach for efficiently screening cardiotoxic components from complex herbal matrices, which enhances screening accuracy and throughput. The dilemma in predicting cardiotoxicity of CHMs is essentially a problem of “target identification in complex systems.” The value of bioaffinity chromatography lies in its first provision of a “mechanism-driven” screening paradigm, which can directly pinpoint components that engage in harmful interactions with core cardiac targets, thereby transforming safety assessment from reactive analysis to proactive warning. Despite challenges in target stability and in vitro–in vivo translation, affinity-based strategies hold great promise for shifting CHM safety evaluation from reactive monitoring to proactive prediction. Future research should focus on developing standardized, multitarget screening platforms and building comprehensive “component–target–toxicity” databases to support evidence-based herbal medicine practice.